These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29874996)

  • 1. Aggregation of Recombinant Monoclonal Antibodies and Its Role in Potential Immunogenicity.
    Ignjatovic J; Svajger U; Ravnikar M; Molek P; Zadravec D; Paris A; Strukelj B
    Curr Pharm Biotechnol; 2018; 19(4):343-356. PubMed ID: 29874996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of
    Morgan H; Tseng SY; Gallais Y; Leineweber M; Buchmann P; Riccardi S; Nabhan M; Lo J; Gani Z; Szely N; Zhu CS; Yang M; Kiessling A; Vohr HW; Pallardy M; Aswad F; Turbica I
    Front Immunol; 2019; 10():601. PubMed ID: 31001248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sorting.
    Telikepalli S; Shinogle HE; Thapa PS; Kim JH; Deshpande M; Jawa V; Middaugh CR; Narhi LO; Joubert MK; Volkin DB
    J Pharm Sci; 2015 May; 104(5):1575-91. PubMed ID: 25753756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free sulfhydryl in recombinant monoclonal antibodies.
    Zhang W; Czupryn MJ
    Biotechnol Prog; 2002; 18(3):509-13. PubMed ID: 12052067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates.
    Kessler JA; McKenna PM; Emini EA; Chan CP; Patel MD; Gupta SK; Mark GE; Barbas CF; Burton DR; Conley AJ
    AIDS Res Hum Retroviruses; 1997 May; 13(7):575-82. PubMed ID: 9135875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of aggregation in therapeutic monoclonal antibodies subjected to stress and long-term stability tests by analyzing size exclusion liquid chromatographic profiles.
    Hernández-Jiménez J; Martínez-Ortega A; Salmerón-García A; Cabeza J; Prados JC; Ortíz R; Navas N
    Int J Biol Macromol; 2018 Oct; 118(Pt A):511-524. PubMed ID: 29944945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of automated Wes system as an analytical and characterization tool to support monoclonal antibody drug product development.
    Wang J; Valdez A; Chen Y
    J Pharm Biomed Anal; 2017 May; 139():263-268. PubMed ID: 28069351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics.
    Joubert MK; Deshpande M; Yang J; Reynolds H; Bryson C; Fogg M; Baker MP; Herskovitz J; Goletz TJ; Zhou L; Moxness M; Flynn GC; Narhi LO; Jawa V
    PLoS One; 2016; 11(8):e0159328. PubMed ID: 27494246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics.
    Wullner D; Zhou L; Bramhall E; Kuck A; Goletz TJ; Swanson S; Chirmule N; Jawa V
    Clin Immunol; 2010 Oct; 137(1):5-14. PubMed ID: 20708973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streamlining the polishing step development process via physicochemical characterization of monoclonal antibody aggregates.
    Doss HR; Raman M; Knihtila R; Chennamsetty N; Wang D; Shupe A; Mussa N
    J Chromatogr A; 2019 Aug; 1598():101-112. PubMed ID: 30954243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells.
    Fagnoni FF; Takamizawa M; Godfrey WR; Rivas A; Azuma M; Okumura K; Engleman EG
    Immunology; 1995 Jul; 85(3):467-74. PubMed ID: 7558137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical Characterization and Innate Immunogenicity of Aggregated Intravenous Immunoglobulin (IGIV) in an In Vitro Cell-Based Model.
    Moussa EM; Kotarek J; Blum JS; Marszal E; Topp EM
    Pharm Res; 2016 Jul; 33(7):1736-51. PubMed ID: 27037576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity Risk Assessment of Spontaneously Occurring Therapeutic Monoclonal Antibody Aggregates.
    Swanson MD; Rios S; Mittal S; Soder G; Jawa V
    Front Immunol; 2022; 13():915412. PubMed ID: 35967308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and consequences of recombinant protein isoforms: implications for biological potency.
    Federici MM; Venkat K; Bam N; Patel K; Dal Monte PR; Fernie B; Hensley P; Carr S; Baldoni J; Truneh A; Erickson J
    Dev Biol (Basel); 2003; 113():53-7; discussion 113-4. PubMed ID: 14620852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells.
    Hock BD; Starling GC; Daniel PB; Hart DN
    Immunology; 1994 Dec; 83(4):573-81. PubMed ID: 7875738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cells co-stimulate peripheral blood mononuclear cell responses to monoclonal antibody TGN1412 in culture.
    Findlay L; Sharp G; Fox B; Ball C; Robinson CJ; Bird C; Stebbings R; Eastwood D; Wadhwa M; Poole S; Thorpe R; Thorpe SJ
    Cytokine; 2011 Jul; 55(1):141-51. PubMed ID: 21493088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo modifications of recombinant and human IgG antibodies.
    Liu H; Ponniah G; Zhang HM; Nowak C; Neill A; Gonzalez-Lopez N; Patel R; Cheng G; Kita AZ; Andrien B
    MAbs; 2014; 6(5):1145-54. PubMed ID: 25517300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for the assessment of protein aggregates in pharmaceutical biotech product development.
    den Engelsman J; Garidel P; Smulders R; Koll H; Smith B; Bassarab S; Seidl A; Hainzl O; Jiskoot W
    Pharm Res; 2011 Apr; 28(4):920-33. PubMed ID: 20972611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
    Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
    Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma.
    Beerli RR; Bauer M; Fritzer A; Rosen LB; Buser RB; Hanner M; Maudrich M; Nebenfuehr M; Toepfer JA; Mangold S; Bauer A; Holland SM; Browne SK; Meinke A
    MAbs; 2014; 6(6):1608-20. PubMed ID: 25484038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.